Canada-based Aralez Pharmaceuticals has completed the divestment of more than 20 medicines under its portfolio to Nuvo Pharmaceuticals for a total consideration of $110m......
Nuvo Pharmaceuticals has been informed by Aralez Pharmaceuticals that Nuvo's previously announced acquisition of Aralez's Canadian business and the Vimovo royalty stream ......
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced financial results for the fourth quarter and year ended December 31, 2017.